PATENT CLAIM ANALYSIS

Application Number: 16131003
Application Type: Utility
Filing Date: 2018-09
Publication Date: 2019-01
Patent Classification: ["530", "350000"]

Abstract:
The invention herein disclosed is related to epitopes useful in methods of diagnosing, treating, and preventing coeliac disease. Therapeutic compositions which comprise at least one epitope are provided.

Claim (Index 51):
A method of determining whether a composition is capable of causing coeliac disease comprising determining whether a protein capable of being modified by a transglutaminase to an oligopeptide sequence as defined in  claim 38  is present in the composition, the presence of the protein indicating that the composition is capable of causing coeliac disease.

Metadata:
- Claim Count in Document: 68.0
- Percentile: 97.0
- Lexical Diversity: 1.06667
- Patent Class: 530.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['14630004', '13541864', '10516837', '10089700', '11630818']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.678308947181481
- 35 USC 102 Novelty (BERT): 0.5641802443101077
- Combined Prediction Score: 0.6668960768943437
- Mean Citation Score: 413.16597999999993
- Max Citation Score: 487.38614
- Similarity Product: 319.92111689133407

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test